FDA Investigator Dorothy P Kramer
Dorothy P Kramer has inspections in 3 countries as of 22 Sep 2023. Dorothy P Kramer has collaborated with a combined 1105 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Spain,
India
Co-Investigator(s):
Alan P Kurtzberg,
Anastasia M Shields,
Ann B Borromeo,
Arsen Karapetyan,
Benita C Okeke,
Bonita S Chester,
Brandon P Thompson,
Cassandra L Abellard,
Christopher N Tran,
Christopher S Keating,
Clinton J Lott,
Damaris Y Hernandez,
Dianiris C Ayala,
Dillard H Woody, Jr,
Edward Deberry,
Ernest A Clausnitzer,
Francis A Guidry,
Israel Juarbe,
Ivis Lnegron Torres,
Jamirya S Weatherly,
Jared P Stevens,
Jason P Aun,
Jennifer Lalama,
Joanne E King,
Jocelyn C Turner,
John J Bernal,
June P Page,
Karen M Rodriguez,
Karissa J Mccaw,
Kevin P Foley,
Kham Phommachanh,
Kristy A Zielny,
Libia M Lugo,
Lillie D Witcher,
Linda F Murphy,
Lloyd D Payne,
Loan T Tran,
Margaret M Annes,
Mark R Mcclain,
Marvin D Jones,
Melanie M Walker,
Nicole E Knowlton,
Oluwasefunm Agbanigo,
Parul M Patel,
Paul A Bonneau,
R Edwadebey Deberry,
Rachael L Cook,
Regan T Harp,
S Michaelith Smith,
Samantha J Bradley,
Sangeeta M Khurana, PhD,
Sharon Giamberini,
Shawn E Larson,
Shelby N Marler,
Sidney M Smith,
Sonya M Edmonds,
State Agency,
Stephanie C Milan,
Tamil Arasu, PhD,
Tonya R Johnson,
Vicky L Cruz,
Walden H Lee,
William J Leonard
Dorothy P Kramer's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2022 | FDA 483 | Klocke of America, Inc. - Form 483, 2022-03-30 |
December, 2022 | FDA 483 | RAPHA HEALTH NETWORK INTERNATIONAL INC - Form 483, 2022-12-16 |
September, 2022 | FDA 483 | Dharma Research, Inc. - Form 483, 2022-09-30 |
June, 2023 | FDA 483 | Lifecycle Biotechnologies, LP - Form 483, 2023-06-23 |
June, 2023 | FDA 483 | LIFECYCLE BIOTECHNOLOGIES, LP - Form 483, 2023-06-23 |
July, 2023 | FDA 483 | King Bio Inc. - Form 483, 2023-07-28 |
May, 2022 | FDA 483 | Conopco, Inc. d/b/a Unilever - Form 483, 2022-05-27 |
November, 2022 | FDA 483 | PD-Rx Pharmaceuticals Inc. - Form 483, 2022-11-10 |
November, 2023 | FDA 483 | Halocarbon Life Sciences, LLC - Form 483, 2023-11-03 |
January, 2024 | FDA 483 | Kesin Pharma Corporation - Form 483, 2024-01-19 |
February, 2024 | FDA 483 | Medipharm Laboratories, Inc - Form 483, 2024-02-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more